Renalytix RNLXY
OTC RNLXY
$3.70 -0.09 (-2.37%)
At close: Nov 6, 2026 · 4:00 PM EST

Renalytix (RNLXY) Current Deferred Revenue (2021 - 2022)

Updated

Renalytix's Current Deferred Revenue came in at $39,000 for fiscal Q1 2023 (quarter ended Sep 30, 2022), down 15.2% from the prior quarter.

Analysis

Renalytix (RNLXY) Current Deferred Revenue (2021 - 2022) Analysis & Trends

At the end of FY2022 (ended Jun 30, 2022), Renalytix's Current Deferred Revenue was $46,000, down 62.3% from FY2021.

  • Going back by fiscal year, Current Deferred Revenue was $122,000 in FY2021.
  • Business Quant data shows RNLXY's Current Deferred Revenue at $46,000 (Q4 2022), $67,000 (Q3 2022) and $67,000 (Q2 2022) in the three fiscal quarters before Q1 2023.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 39,000.00
Jun 30, 2022 46,000.00
Mar 31, 2022 67,000.00
Dec 31, 2021 67,000.00
Jun 30, 2021 122,000.00
API Access

Renalytix Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=RNLXY&period=max&api_key=YOUR_API_KEY